We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$15M
AUM Growth
-$170M
Cap. Flow
-$69.6M
Cap. Flow %
-462.87%
Top 10 Hldgs %
51.84%
Holding
132
New
31
Increased
18
Reduced
10
Closed
70

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.45M
2
IHI icon
iShares US Medical Devices ETF
IHI
+$875K
3
RDCM icon
Radcom
RDCM
+$577K
4
APLS
Apellis Pharmaceuticals
APLS
+$491K
5
INSM icon
Insmed
INSM
+$431K

Top Sells

Rank Stock Value
1
MYO icon
Myomo
MYO
+$7M
2
ASPN icon
Aspen Aerogels
ASPN
+$6.96M
3
INDI icon
indie Semiconductor
INDI
+$4.63M
4
SCPH
scPharmaceuticals
SCPH
+$4.31M
5
TGAN
Transphorm, Inc. Common Stock
TGAN
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 29.82%
2 Technology 27.27%
3 Real Estate 20.31%
4 Communication Services 5.72%
5 Consumer Staples 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFH icon
76
PUT
Bread Financial
BFH
$4.37B
– –
-10,600
Closed -$3.34K
BKTI icon
77
BK Technologies
BKTI
$300M
– –
-81,951
Closed -$1M
BWAY
78
Brainsway
BWAY
$611M
– –
-517,068
Closed -$1.68M
CCL icon
79
PUT
Carnival Corporation Ltd
CCL
$38.1B
– –
-82,100
Closed -$821
CDLX icon
80
Cardlytics
CDLX
$21.7M
– –
-4,774
Closed -$440K
CGTX icon
81
Cognition Therapeutics
CGTX
$79.6M
– –
-508,719
Closed -$941K
CLRB icon
82
Cellectar Biosciences
CLRB
$20.5M
– –
-23,130
Closed -$1.92M
CNK icon
83
PUT
Cinemark Holdings
CNK
$4.24B
– –
-118,000
Closed -$8.85K
COF icon
84
Capital One
COF
$128B
– –
-20,723
Closed -$2.72M
COYA icon
85
Coya Therapeutics
COYA
$98.3M
– –
-92,667
Closed -$687K
DCTH icon
86
Delcath Systems
DCTH
$422M
– –
-294,248
Closed -$1.22M
ELUT icon
87
Elutia
ELUT
$37.9M
– –
-478,542
Closed -$1.03M
ELVA
88
Electrovaya
ELVA
$407M
– –
-820,538
Closed -$2.51M
EVLV icon
89
Evolv Technologies
EVLV
$995M
– –
-11,229
Closed -$53K
EXR icon
90
Extra Space Storage
EXR
$31.3B
– –
-1,400
Closed -$224K
FC icon
91
Franklin Covey
FC
$242M
– –
-34,405
Closed -$1.5M
FE icon
92
PUT
FirstEnergy
FE
$28B
– –
-10,000
Closed -$500
FKWL icon
93
Franklin Wireless
FKWL
$26.9M
– –
-98,826
Closed -$335K
GEO icon
94
PUT
The GEO Group
GEO
$4.13B
– –
-115,400
Closed -$2.96K
GES
95
PUT
DELISTED
Guess Inc
GES
– –
-18,200
Closed -$10.5K
GILT icon
96
Gilat Satellite Networks
GILT
$834M
– –
-75,643
Closed -$462K
GSIT icon
97
GSI Technology
GSIT
$215M
– –
-238,269
Closed -$629K
HASI icon
98
PUT
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
– –
-37,700
Closed -$4.71K
HGV icon
99
Hilton Grand Vacations
HGV
$3.59B
– –
-65,976
Closed -$2.65M
INDI icon
100
indie Semiconductor
INDI
$682M
– –
-570,512
Closed -$4.63M
2 3
4
5 6

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Worth Venture Partners held 132 positions worth $15M, down 92% from $185M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Worth Venture Partners withdrew a net $69.6M in Q1 2024, closing 70 positions and reducing 10 holdings. Its most notable exit was Myomo, an estimated $7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 21% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Worth Venture Partners opened a new position in Johnson & Johnson worth $1.44M.

  • Worth Venture Partners's largest Q1 2024 buy was Johnson & Johnson: 9,100 shares worth $1.44M.
  • Worth Venture Partners added most to Arteris in Q1 2024, an estimated $185K increase.
  • Worth Venture Partners's biggest Q1 2024 reduction was scPharmaceuticals, cutting an estimated $4.31M.
  • Worth Venture Partners fully exited Myomo in Q1 2024, selling an estimated $7M.
  • Worth Venture Partners's ten largest holdings make up 52% of its $15M portfolio in Q1 2024.
  • Worth Venture Partners opened 31 new positions and closed 70 in Q1 2024.
  • Worth Venture Partners's portfolio value fell 92% quarter-over-quarter to $15M.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.